Keywords
Cells
Cancer
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To elucidate the impact of fasting on the stimulation of NK cells in cancer treatment. Literature Review: Natural Killer (NK) cells play a crucial role in innate immunity, particularly in the elimination of tumor cells. In this context, fasting and fasting-mimicking diets (FMDs) can enhance NK cell activity, fostering a tumor microenvironment less conducive to growth. By modulating immune response, these practices reduce stimuli that promote cancer development while potentially minimizing the adverse effects common in oncological treatments, such as chemotherapy. Thus, integrating nutritional and immunological strategies positions fasting as a potential adjuvant in anticancer therapies, emphasizing the need for personalized adaptations to ensure both safety and maximization of treatment benefits. Final considerations: While fasting offers benefits in cancer treatment, such as strengthening NK cell response, it is essential to carefully assess risks and adjust fasting protocols, especially for advanced cancer patients, ensuring personalized monitoring to maximize therapeutic effects and minimize potential complications.
References
ABBAS AK, et al. Imunologia celular e molecular. Rio de Janeiro: Elsevier, 2020; 9(1-4): 7-13.
ANTUNES F, et al. Autophagy and intermittent fasting: the connection for cancer therapy? Clinics, 2018; 73: 814.
BRANDHORST S, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metabolism, 2015; 22(1): 86-99.
CAFFA I, et al. Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition. Oncotarget, 2015; 6(14): 11820-11832.
CARDIM ES, et al. DIABETES MELLITUS TIPOS 1 E 2 E ASPECTOS IMUNOLÓGICOS. Revista Ibero-Americana de Humanidades, Ciências e Educação, 2024; 10(10): 927-945.
CHENG CW, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell, 2014; 14(6): 810-823.
CHU J, et al. Natural killer cells: a promising immunotherapy for cancer. Journal of Translational Medicine, 2022; 20(1): 240.
CORTELLINO S, et al. Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects. Nature Communications, 2023; 14(1).
COSTA AF de O. Caracterização fenotípica e funcional de células Natural Killer no diagnóstico e avaliação pós-tratamento de leucemia mieloide aguda. [s.l.]: Universidade de São Paulo, Agência USP de Gestão da Informação Acadêmica (AGUIA), 2023.
DORFF TB, et al. Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC cancer, 2016; 16: 1-9.
GROOT DS, et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nature Communications, 2020; 11(1): 3083.
GROOT DS, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer, 2015; 15: 652.
HARVIE MN, et al. Intermittent energy restriction induces changes in breast gene expression and systemic metabolism. Breast Cancer Research, 2016;18: 1-14.
KOPPOLD DA, et al. LBA94 Effects of short-term fasting on quality of life as an add-on option during chemotherapy. Annals of Oncology, 2023; 34: 1335.
LIU S, et al. NK cell-based cancer immunotherapy: from basic biology to clinical development. Journal of hematology & oncology, 2021; 14 (1): 7.
LONGO VD e MATTSON MP. Fasting: Molecular mechanisms and clinical applications. Cell metabolism, 2014; 19(2): 181–192.
LUGTENBERG RT, et al. Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial. Breast cancer research and treatment, 2021; 185(3): 741–758.
MAROFI F, et al. CAR-NK cell in cancer immunotherapy; A promising frontier. Cancer science, 2021; 112 (9): 3427–3436.
MATTSON MP, et al. Impact of intermittent fasting on health and disease processes. Ageing research reviews, 2017; 39: 46-58.
NETO JAC, et al. Avaliação da Expressão das Células NK no Câncer de Próstata após Prostatectomia Radical. Revista Científica Hospital Santa Izabel, 2023; 7(4): 159-167.
PIO R, et al. Fasting and fasting-mimicking conditions in the cancer immunotherapy era. Journal of Physiology and Biochemistry, 2024.
PLOTTI F, et al. Diet and chemotherapy: The effects of fasting and ketogenic diet on cancer treatment. Chemotherapy, 2020; 65(3): 77–84.
ROSA NR, et al. Estudo das Células Natural Killer (NK) através da técnica de citometria de fluxo para aplicação em terapias contra o Câncer - uma revisão bibliográfica. Brazilian Journal of Health Review, 2024; 7(4): 71070.
TERRÉN I, et al. NK cell metabolism and tumor microenvironment. Frontiers in immunology, 2019; 10: 2278.
UDUMULA MP, et al. Intermittent Fasting induced ketogenesis inhibits mouse epithelial ovarian tumors by promoting anti-tumor T cell response. bioRxiv.org: the preprint server for biology, 2023.